Desferoxamine protects against hemophilic arthropathy through the upregulation of HIF-1α-BNIP3 mediated mitophagy

Life Sciences(2023)

引用 1|浏览3
暂无评分
摘要
In conclusion, DFO could protect against HA development via HIF-1α-BNIP3 mediated mitophagy, suggesting DFO might be a potential therapeutic supplement for HA treatment.
更多
查看译文
关键词
Hemophilic arthropathy,Desferoxamine,Iron overload,HIF-1α-BNIP3,Mitophagy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要